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ABSTRACT Whereas research has suggested that drug-involved men are at dispropor-
tionately high risk of engaging in transmission risk behaviors for HIV and of
perpetrating intimate partner violence (IPV) against women, only a few cross-sectional
studies have examined the relationship between IPV and HIV/sexually transmitted
infection (STI) transmission risks among heterosexual, drug-involved men. This study
builds on previous cross-sectional research by using a longitudinal design to examine
the temporal relationships between perpetration of IPV and different HIV/STI
transmission risks among a random sample of 356 men on methadone assessed at
baseline (wave 1), 6 months (wave 2), and 12 months (wave 3). The findings indicate
that (1) perpetration of IPV in the past 6 months at wave 1 was associated with having
more than one intimate partner, buying sex, and sexual coercion at subsequent waves
and that (2) noncondom use, injecting drugs, and sexual coercion at wave 1 were
associated with subsequent IPV. The temporal relationships between perpetration of
IPV and HIV risks found in this study underscore the need for HIV prevention
interventions targeting men on methadone to consider IPV and HIV risks as
cooccurring problems.
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INTRODUCTION
Substantial research has found that drug-involved men are at disproportionately
high risk of engaging in transmission risk behaviors for HIV and other sexually
transmitted infections (STIs)1–4 as well as of perpetrating intimate partner violence
(IPV) against women.5–14 Over the past decade, mounting evidence also has
documented multifaceted relationships between experiencing IPV and HIV/STI
transmission risks among drug-involved women.14–16 However, to our knowledge,
only a handful of recent studies have examined the relationships between
perpetration of IPV and HIV/STI transmission risks among heterosexual men and
only one study has focused on drug-involved men.
This nascent research has suggested multiple relationships between male
perpetration of IPV and HIV transmission risks. A cross-sectional study among 104
male inmates that examined their responses to condom requests by their female
partners found that the severity of male perpetration of IPV was associated with more
coercive responses to condom request messages that implied women_s infidelity.17 A
cross-sectional study of a random sample of 726 sexually active individuals found
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that perpetration of IPV was associated with having unprotected intercourse.18
Another recent cross-sectional study of a nonrandom sample of 283 sexually active,
young adult men recruited from an urban community health center found that
participants who reported perpetration of IPV during the past year were significantly
more likely to report (1) inconsistent or no condom use, (2) forced vaginal sex
without a condom, and (3) sex with multiple female partners.19 A cross-sectional
study with a nonrandom sample of 273 men in methadone maintenance treatment
programs (MMTPs) found that men who reported perpetrating IPV were almost
4 times more likely to have had more than one intimate partner and 2.6 times
more likely to have had sex with a drug injecting sexual partner than their
counterparts.20 This emerging research on the relationship between perpetration
of IPV and HIV/STI transmission risks among drug-involved men in heterosexual
relationships remains limited in terms of cross-sectional designs, nonrandom
samples, or failure to adequately control for potentially confounding variables.
Longitudinal research with improved methods of control for potential confounders is
needed to provide stronger evidence for direct associations between perpetration of
IPV and different HIV/STI transmission risks among drug-involved men.
Research on the relationship between experiencing IPV and HIV/STI transmission
risks among heterosexual women has elucidated several pathways linking IPV
and HIV/STI transmission risks that may also exist among male perpetrators,
including (1) engaging in unprotected sex,14,21–34 (2) higher rates of STIs,29,35–39
(3) sex with multiple sexual partners,28,29,40 (4) disclosure of an STI or positive
HIV status,41,42 (5) trading sex for drugs or money,36,43 (6) having a risky sexual
partner (e.g., one who injects drugs is HIV-positive and/or has had sex with
multiple partners),28,29,33,36,38,43–45 (7) forced sex,43,46,47 and (8) injecting drug
use.20
This study builds on previous research linking perpetration of IPV and HIV/STI
transmission risks by examining the temporal relationships between perpetration of
IPV and different HIV/STI transmission risks among a random sample of men in
MMTP using a longitudinal design and propensity score matching. This study
examines two hypotheses. The first hypothesis (H1) is: self-reported sexual HIV/STI
transmission risks at baseline (i.e., wave 1) will increase the likelihood of perpetrating
physical and/or injurious IPVat 6- and 12-month follow-up assessments (i.e., waves 2
and 3) over the subsequent year. The second hypothesis (H2) is: perpetration of
physical and/or injurious IPVat wave 1 will increase the likelihood of sexual HIV/STI
transmission risks at subsequent waves 2 and 3 (i.e., 6- and 12-month follow-up).
MATERIALS AND METHODS
Random Sampling and Recruitment Procedures
We randomly selected 1,300 men to be screened for eligibility for this study from a
total population of 2,067 men who were enrolled as patients in seven MMTP
clinics in Harlem, New York City. Eligible participants included men, aged 18 or
over, who were enrolled at an MMTP for at least 3 months and who reported
having had a sexual relationship with a woman during the past year described as a
girlfriend, spouse, regular sexual partner, or the mother of his children. MMTP
counselors notified potential participants of their selection for the study and invited
them to contact research assistants (RAs). Once a potential participant made
contact with an RA, the RA would describe the study and give him an opportunity
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to ask any questions. If the potential participant expressed interest in the study, the
RA would complete informed consent and conduct a brief screening interview to
determine eligibility.
Of the 1,300 randomly selected men, 25 men were excluded from screening
because they did not demonstrate sufficient English-speaking proficiency to provide
informed consent and three men were excluded from screening because of a severe
cognitive or psychiatric impairment that interfered with their ability to provide
informed consent. Of the remaining 1,272 randomly selected men, 774 men agreed
to participate and completed a 15-min screening interview, 194 refused to
participate in the study, and 304 missed two or more screening appointments and
did not participate. Of the 774 men who were screened, 499 met eligibility criteria
of whom 356 (71%) agreed to participate and completed a baseline assessment.
Data for the longitudinal study were collected between 1999 and 2003. Eligible
participants were assessed with repeated measures at baseline (wave 1), at 6-month
follow-up (wave 2), and at 12-month follow-up (wave 3). For all three assessments,
male RAs administered face-to-face structured interviews, which averaged 1.5 h in
length. Compensation entailed $5 for participating in the screening, $30 for
participating in the face-to-face baseline interview, $35 for the 6-month interview,
and $40 for the 12-month interview. The RAs received 24 h of training in
recruitment and interviewing skills. The Institutional Review Boards of the
participating MMTPs and Columbia University approved the protocol for this
study.
Measurement
The repeated assessments covered self-reported sociodemographics, relationship
characteristics, drug use and drug risk behaviors, sexual HIV risk behaviors, self-
reported STIs, and participant reports on partner_s drug-related and sexual HIV
risk behaviors. Information on a maximum of two current female intimate partners
was elicited from participants.
Sociodemographic and relationship characteristics included: age, race/ethnicity,
education, employment status, length of stay in most recent methadone maintenance
treatment, number of intimate partners in past 6 months, length of relationship with
intimate partner, type of relationship, and contribution of participant and partner_s
to household expenses.
The Drug Use and Risk Behavior Questionnaire was developed by the
investigators to provide frequency counts of binge drinking, injecting drug use, and
using crack/cocaine, heroin, marijuana, and other illicit drugs in the past 6 months.
Internal consistency was assessed with 800 subjects and yielded a reliability of
0.80.48,49 For the purpose of this study, we dichotomized use of each drug so that
any use was coded as 1 and nonuse was coded as 0. Binge drinking was defined as
drinking five or more alcoholic drinks within a 6-h period, which is considered a
standard definition of a binge-drinking episode for men.50
Self-reported data on sexual HIV/STI risks were measured by the Sexual Risk
Behavior Questionnaire (SRBQ). The internal consistency of the SRBQ has yielded an
a reliability of 0.80.44 The SRBQ ascertains sexual behaviors within past 6 months,
including (1) frequency of condom use (i.e., always, sometimes, or never) during
vaginal and anal sex with intimate, casual, and paying partner(s); (2) number of
sexual partners; (3) risk factors associated with partners reported by participants
(i.e., partners who inject drugs, are HIV-infected, have had STIs, or who have had sex
with other concurrent partners in the past 6 months); (4) self-reported STIs in past
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6 months; and (5) self-reported HIV status.44 A positive response to an HIV/STI
transmission risk at wave 2 (6-month follow-up) and/or wave 3 (12-month follow-
up) was coded as 1 for that outcome; a negative response to the HIV risk outcome
for both waves 2 and 3 was coded as 0. With respect to condom use and condom
request variables, participants indicating at waves 2 and 3 that they always used
or requested condoms were coded as Balways=2^ whereas participants reporting
they sometimes used or requested condoms were coded as Bsometimes=1.^
Participants who reported never using or requesting condoms at wave 2 and wave
3 were coded as Bnever=0.^
Perpetration of physical and injury-related IPV was assessed using the revised
Conflict Tactics scales (CTS2).49 The CTS2 contains two subscales measuring
physical and injury-related IPV in the past 6 months, which provide an overall
prevalence of IPV that we define as Bphysical and/or injury-related IPV.^ We
examined IPV across intimate partners at each wave. The CTS2 also has a subscale
that assesses sexual coercion, which was considered as an HIV/STI risk variable
because it contains items on coerced sex without condoms. Internal consistency of
the CTS2 subscales ranges between 0.79 and 0.95.49 At all waves respondents who
reported perpetrating any physical and/or injury-related IPV in the prior 6 months
were coded as 1 for IPV and those who did not report perpetrating any physical
and/or injury-related IPV in prior 6 months were coded as 0.
Data Analysis
Of the 356 participants, who completed the baseline interview (wave 1), 287 (81%)
completed the 6-month follow-up interview (wave 2) and 278 (78%), the 12-month
interview (wave 3). Similarities on the baseline measures were found among those
who were retained at follow-ups and dropouts, except on age, ethnicity, and
injection drug use. Multiple imputation via the Multivariate Imputation by Chained
Equations module in Stata8 was used to reduce the potential for bias resulting from
missing data and differential attrition.51–54
Propensity scores were calculated using attributes for observed confounders and
treatment variables observed at wave 1 (baseline). Propensity score matching is a
technique used in observational studies to select groups, which are similar on average
with respect to potential confounders.55–59 The confounders included (1) sociodemo-
graphic variables (i.e., age, race/ethnicity, education, length of time in MMTP, and
employment status), (2) relationship characteristics (i.e., type of intimate relation-
ship(s), length of relationship, and financial dependency), and (3) substance use (i.e.,
participant_s use of illicit drugs and binge drinking in past 6 months, participant_s
reports on intimate partner_s substance use in past 6 months). The selection of these
potential confounders was based on previous research on factors associated with
both IPV and sexual transmission risks among drug-involved, heterosexual men and
women.14,20 The matching procedure was performed by BPSMATCH2^ (a shareware
module in Stata8).60 The diagnostics of balance on all covariates were also conducted
for adequacy of matched groups.61
After selecting a final sample of participants using propensity score matching,
multiple logistic regression analyses were conducted to test each hypothesis. Causal
effect sizes were estimated by odds ratios (ORs) and their associated 95%
confidence intervals (CI), adjusting for the same set of confounders used in the
propensity score matching. For all evaluations testing H1, we compared participants
who reported perpetrating physical or injurious-related IPV in the prior 6 months at
wave 1 (baseline) with men who did not perpetrate such violence on HIV risk
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outcomes reported in wave 2 (6-month follow-up) and/or wave 3 (12-month follow-
up). For all evaluations testing H2, the treatment variables are HIV risk factors
measured at wave 1 and the outcome variable is perpetration of physical and injury-
related IPV at wave 2 and/or wave 3.
RESULTS
Sociodemographic and Relationship Characteristics
Sociodemographic and relationship characteristics collected at wave 1 are presented
in Table 1. The majority of participants self-identified as Latino or African
American. The men_s mean age was almost 44 years old (SD=8.5) and their
average level of education was 11.6 years (SD=2.3). Almost half of the sample
(47%) was unemployed and about one tenth had been incarcerated in the past 6
months. Participants had been in methadone maintenance treatment for an average
of 8.3 years (SD=7.4). In terms of relationship characteristics, the average length of
relationship with the main intimate partner was 10.5 years (SD=9.2). More than
half indicated that they were married or had a common-law marriage with their
main intimate partners. Likewise, more than half were living with their partner. The
mean age of their main partners was almost 40 years old (SD=8.9). The majority of
partners were Latina or African American. About half of the partners were
unemployed.
TABLE 1 Sociodemographic characteristics and relationship characteristics (N=356)
Sociodemographic characteristics
Age (years) x=43.6 SD=8.5
Years of schooling x=11.6 SD=2.3
Income (dollars per month) x=989 SD=958
Race/Ethnicity (n, %)
Latino 161 45%
African American 134 38%
Unemployed in the past 6 months (n, %) 169 47%
Incarcerated in the past 6 months (n, %) 39 11%
Duration of methadone treatment (years) x=8.3 SD=7.4
Current methadone dose (mg) x=84 SD=31
Relationship characteristics
Partner_s age (years) x=39.5 SD=8.9
Partner_s years of schooling x=12.3 SD=2.7
Partner_s race/ethnicity (n, %)
Latino 157 44%
African American 123 35%
Partner unemployed in the past 6 months (n, %) 171 48%
Partner incarcerated in the past 6 months (n, %) 16 4%
Relationship type with partner (n, %)
Married (legally) 111 31%
Married (Common-law) 101 28%
Living with partner (n, %) 196 55%
Length of relationship (years) x=10.5 SD=9.2
% contributed to partner_s household expenses x=39% SD=33%
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Substance Abuse-related Characteristics
In the 6 months before wave 1 (baseline), about half of the participants (50%)
reported heroin use, 37% reported crack/cocaine use, 38% marijuana use, 72%
reported any illicit drug use, and 26% reported binge drinking. At wave 1 (baseline),
42% of the participants reported that their intimate partners used an illicit drug in
the prior 6 months, 22% reported partner use of crack/cocaine, 18% had a partner
who used heroin, and 29% reported their partners engaged in binge drinking.
Prevalence of IPV
Prevalence rates of perpetrating physical and/or injurious IPV during the prior 6
months as reported at each wave of the study are presented in Table 2. The prevalence
of perpetrating physical and/or injurious IPV was 28% for wave 1 (baseline), 34%
for wave 2 (6-month follow-up), and 31% for wave 3 (12-month follow-up). About
half (47%) of the sample reported perpetrating physical and/or injurious IPV during
the follow-up period covering waves 2 and 3.
HIV/STI Risk
At wave 1 (baseline), more than a third of the participants reported consistent condom
use during vaginal sex with their intimate partners in the past 6 months. Five percent
self-reported having had an STI in the past 6 months and 15% reported testing positive
for HIV. About one quarter indicated that they had more than one intimate partner and
8% reported buying sex for money or drugs. Less than one quarter of the participants
TABLE 2 Prevalence of IPV, condom use behaviors, and HIV/STI risks at three time points
Baseline (%) 6 months (%) 12 months (%)
Physical and injurious IPV 28 34 31
Condom use during vaginal sex
Always 35 50 50
Sometimes 16 9 10
Never 49 41 40
Any STI 5 12 9
HIV status
Positive 15 19 19
Negative 75 71 72
Unknown 10 10 9
Having 91 intimate partner 24 26 22
Buying sex 8 16 11
Injected drugs 22 29 27
Partner HIV status
Positive 7 9 10
Negative 88 80 82
Unknown 5 11 8
Partner having 91 partner 6 13 11
Partner injected drugs 8 7 5
100% protected vaginal sex with other
nonmain partnersa
88 88 86
Any sexual coercion 17 25 18
aFor B100% protected vaginal sex with other nonmain partners,^ those who did not have any outside partner
were coded as 100% protected.
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injected drugs in the past 6 months. In addition to these risks, 7% of the men reported
that their intimate partners were HIV-positive, 6% reported that their partners had an
outside partner, and 8% indicated that their partners injected drugs in the past 6
months. Prevalence rates of HIV risks were consistent over time.
Hypotheses Testing
H1: Perpetration of IPV Increases the Likelihood of Subsequent HIV/STI
Risk The findings presented in Table 3 are the adjusted ORs for reporting HIV/
STI risks at wave 2 (6-month follow-up) and/or wave 3 (12-month follow-up)
associated with perpetrating physical and/or injurious IPV in the prior 6 months at
wave 1 (baseline). Compared to men who do not report physical and/or injurious
IPV, men who report perpetrating physical and/or injurious IPV in the prior 6 months
at wave 1 (baseline) were significantly more likely to indicate that they have had
more than one intimate partner (OR=2.9, CI=1.2, 7.1) and more likely to buy sex for
money or drugs (OR=3.3, CI=1.1, 10.4) at subsequent waves (6 and 12-month
follow-up). Perpetrators of IPV at wave 1 (baseline) were also significantly more
likely than nonperpetrators to report sexual coercion at subsequent waves (OR=2.9,
CI=1.2, 6.6). In addition, perpetrators of IPV at wave 1 were marginally more likely
to report not using condoms consistently with other nonmain partners at subsequent
waves (OR=0.4, CI=0.1, 1.1). No significant associations were found between
perpetration of IPV at wave 1 (baseline) and subsequent self-reported STIs, injection
drug use, frequency of condom use, requests for condom use, and subsequent
partner-related risk factors (i.e., injecting drugs, having more than one partner).
H2: HIV/STI Risks Increase the Likelihood of Perpetration of IPV Table 4 con-
tains adjusted ORs for perpetrating IPVat subsequent waves associated with reporting
HIV/STI risks in the prior 6 months at wave 1 (baseline). Compared to men who
reported never using condoms in the past 6 months at wave 1, men who sometimes
used condoms in the past 6 months were significantly more likely to report perpetrating
physical and/or injurious IPV at subsequent waves (6- and 12-month follow-up)
(OR=0.3, CI=0.1, 0.8). Inconsistent condom use at wave 1 (baseline) was marginally
associated with subsequent perpetration of IPV (OR=0.5, CI=0.3, 1.1). Men who
reported injecting drugs in the past 6 months at baseline were significantly more likely
than noninjectors to indicate perpetrating IPV at subsequent waves (OR=3.7, CI=1.1,
11.9). Men who indicated any sexual coercion against their partners at baseline were
also significantly more likely than their counterparts to report perpetrating physical or
injurious IPV at subsequent waves (OR=2.6, CI=1.2, 5.4). In addition, having a self-
reported STI in the past 6 months at wave 1 (baseline) was marginally associated with
perpetration of IPV at subsequent waves at the 90% confidence level (OR=5.6,
CI=0.98, 31.6). No support was found for subsequent perpetration of IPV as a
consequence of having a risky partner, having had sex with multiple or commercial
partners, or partner-related risk factors assessed at wave 1 (baseline).
DISCUSSION
To our knowledge, this is the first longitudinal investigation that examines temporal
relationships between perpetrating IPV and HIV/STI transmission risks among a
random sample of drug-involved men in heterosexual, intimate relationships. The
methodology of propensity score matching in combination with multiple logistic
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regression in this longitudinal study allows for a more rigorous method of accounting
for potentially confounding variables and inferring causality. These methodological
advances improve on previous cross-sectional research, which has examined
relationships between male perpetration of IPV and HIV transmission risks.
Collectively, the study findings suggest multiple, temporal relationships between
perpetrating IPV and several HIV/STI risk factors, which mirror relationships
between these cooccurring problems found in studies among drug-involved women.
The first hypothesis that perpetration of IPV increases the likelihood of
presenting subsequent HIV/STI transmission risks was supported for some HIV
risks. The temporal relationship between IPV and engaging in outside relationships
with other intimate or sex exchanging partners is consistent with previous cross-
sectional studies, which have found a significant relationship between these two
variables among heterosexual men as perpetrators19,20,62 and among heterosexual
women as victims of IPV.28–30,40,45,63 These findings may suggest that the
relationship instability associated with IPV may increase the likelihood that men
will engage in outside relationships as an exit strategy or as another form of
retaliation, which may also be considered as a form of psychological IPV. Further
research is needed to examine whether perpetration of IPV among drug-involved
men predicts subsequent changes in partner status (e.g., shifting primary intimate
partners, engaging in concurrent relationships with different types of sexual
partners, and initiating sex with casual or commercial partners) that may, in turn,
result in changes in other HIV risk-related behaviors, like inconsistent condom use.
Moreover, the study findings supported temporal relationships between
perpetration of physical or injurious IPV and sexual coercion, suggesting that the
pathways linking perpetration of physical or injurious IPV and sexual coercion are
bidirectional. Although this finding is not surprising as sexual coercion is
considered a domain of IPV, it does have HIV/STI risk implications. Sexual
coercion has been identified as a risk factor for HIV/STIs as it has been found to be
associated with unprotected sex and rough sex resulting in vaginal lacerations that
may increase the likelihood of HIV/STI transmission.64–66
In addition, the data supported the second hypothesis: an increased likelihood of
subsequent perpetration of IPV was significantly associated with wave 1 reports of
recent injection drug use and noncondom use. The temporal relationship found be-
tween injection drug use and perpetration of IPV is consistent with previous lit-
erature.20 Several qualitative studies suggest that the practice of injecting drugs and
sharing needles between intimate partners is often pervaded with gender-based
inequalities and IPV.67,68 The relationship between perpetration of IPV and incon-
sistent or no condom use has been supported by previous research.19,20 Failure to use
condoms in intimate relationships, especially when other risk factors are present,
such as having an STI or outside partners, may increase the likelihood of relationship
conflict and IPV. The marginal association found between self-reported STIs and
subsequent perpetration of IPV may be related to the impact of the disclosure of an
STI, or alternatively, contracting STIs may be related to sexual affairs outside the
intimate relationship, which may trigger IPV. Here again, future research to identify
the precise sequence of multiple HIV/STI risks that lead to the perpetration of IPV
may further elucidate the causal mechanisms linking these two cooccurring problems.
Limitations
The nonresponse rate limits the generalizability of findings as we do not have data
on whether randomly selected men who did not participate in the screening
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interview may have differed from respondents in terms of the IPV, HIV risk, and
background variables. This study also relies on self-reported data of sensitive
behaviors that are subject to a social desirability bias, which may have influenced
study findings. For example, social desirability bias may have inhibited participants
from disclosing recent perpetration of IPV and other socially undesirable HIV risk
behaviors.
Implications for Intervention
Despite these limitations this study has several implications for designing effective
HIV prevention interventions for this population. The HIV/STI transmission risks
linked with perpetration of IPV among this sample of men suggest the need for HIV
prevention strategies to take into account broader relationship safety issues. To
date, no HIV prevention interventions have been developed and tested for drug-
involved men, who are at risk of perpetrating IPV. Over the past two decades
MMTPs have played an instrumental role in reducing HIV among patients.69
MMTPs may serve as an optimal setting to launch an HIV prevention intervention,
which addresses broader relationship safety issues associated with IPV and HIV/STI
transmission risks among men and their intimate partners.
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